Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers

Area of Science:

• Immunology
• Dermatology
• Biomarker Discovery

Background:

• Vitiligo is a chronic skin condition with unpredictable relapse rates.
• Identifying biomarkers for vitiligo recurrence is crucial for effective management.
• Limited research exists on cytokines as predictive biomarkers for vitiligo relapse.

Purpose of the Study:

• To explore specific cytokines as potential biomarkers for vitiligo recurrence.
• To investigate the association of cytokines with vitiligo disease activity.
• To identify predictive markers for predicting vitiligo relapse.

Main Methods:

• Recruited 92 vitiligo patients and 40 healthy controls.
• Utilized ultrasensitive multiplex cytokine array to measure plasma levels of IFN-γ, CXCL9, CXCL10, CXCL11, IL-6, and IL-15.
• Employed correlation analysis and multivariate logistic regression for data interpretation.

Main Results:

• Elevated levels of IFN-γ, CXCL9, CXCL10, CXCL11, IL-6, and IL-15 were observed in vitiligo patients compared to controls.
• CXCL9 levels correlated with vitiligo disease activity.
• IFN-γ, CXCL9, CXCL10, CXCL11, and IL-6 were significantly higher in recurrent vitiligo cases, demonstrating predictive capability for recurrence.

Conclusions:

• Plasma IFN-γ, CXCL9, CXCL10, CXCL11, and IL-6 show potential as biomarkers for predicting vitiligo recurrence.
• CXCL9 is associated with vitiligo disease activity.
• Interferon-gamma (IFN-γ) is an independent predictor of vitiligo recurrence, suggesting its utility in predictive models.